Literature DB >> 11090646

Blockade of voltage-sensitive Ca(2+)-channels markedly diminishes nitric oxide- but not L-S-nitrosocysteine- or endothelium-dependent vasodilation in vivo.

M D Travis1, A Hoque, J N Bates, S J Lewis.   

Abstract

The aim of this study was to determine the hemodynamic responses elicited by systemic injections of (i) the nitric oxide (NO)-donors, sodium nitroprusside (10 nmol/kg, i.v.) and (Z)-1-(N-methyl-N-(6(N-methylammoniohexyl)amino))diazen-1-ium-1, 2-diolate (MAHMA NONOate, 25 nmol/kg, i.v.), (ii) the endothelium-derived S-nitrosothiol, L-S-nitrosocysteine (100 nmol/kg, i.v.), and (iii) the endothelium-dependent agonist, acetylcholine (1.0 microg/kg, i.v.), in anesthetized rats, before and after injection of the voltage-sensitive Ca(2+)-channel (Ca(VS)(2+)-channel) blocker, nifedipine (500 nmol/kg, i.v.). Before injection of nifedipine, the agents produced similar falls in mean arterial blood pressure, and in hindquarter and mesenteric vascular resistances. The depressor and vasodilator responses elicited by sodium nitroprusside and MAHMA NONOate were markedly attenuated by nifedipine. The falls in mean arterial blood pressure and mesenteric resistance elicited by L-S-nitrosocysteine and acetylcholine were not attenuated but the falls in hindquarter resistance were slightly attenuated by nifedipine. The cyclooxygenase inhibitor, indomethacin (10 mg/kg, i.v.), did not affect the actions of sodium nitroprusside, MAHMA NONOate, L-S-nitrosocysteine or acetylcholine or the effects of nifedipine on the hemodynamic actions of these compounds. The decomposition of sodium nitroprusside (0.2 nmol/ml), MAHMA NONOate (0.5 nmol/ml) and L-S-nitrosocysteine (2 nmol/ml) to NO upon addition to rat blood was not affected by nifedipine (10 microM). These findings suggest that (i) exogenously applied NO relaxes resistance arteries in vivo by inhibition of Ca(VS)(2+)-channels whereas L-S-nitrosocysteine and the non-prostanoid endothelium-derived relaxing factor (EDRF) released by acetylcholine acts by additional mechanisms, and (ii) this EDRF may be an S-nitrosothiol which acts independently of its decomposition to NO.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090646     DOI: 10.1016/s0014-2999(00)00792-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Hypotension induced by activation of the transient receptor potential vanilloid 4 channels: role of Ca2+-activated K+ channels and sensory nerves.

Authors:  Feng Gao; Donna H Wang
Journal:  J Hypertens       Date:  2010-01       Impact factor: 4.844

2.  S-nitrosothiols dilate the mesenteric artery more potently than the femoral artery by a cGMP and L-type calcium channel-dependent mechanism.

Authors:  Taiming Liu; Hobe J Schroeder; Meijuan Zhang; Sean M Wilson; Michael H Terry; Lawrence D Longo; Gordon G Power; Arlin B Blood
Journal:  Nitric Oxide       Date:  2016-05-25       Impact factor: 4.427

3.  S-Nitroso-L-Cysteine Stereoselectively Blunts the Deleterious Effects of Fentanyl on Breathing While Augmenting Antinociception in Freely-Moving Rats.

Authors:  Paulina M Getsy; Santhosh M Baby; Ryan B Gruber; Benjamin Gaston; Tristan H J Lewis; Alan Grossfield; James M Seckler; Yee-Hsee Hsieh; James N Bates; Stephen J Lewis
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

4.  Role of nitric oxide-containing factors in the ventilatory and cardiovascular responses elicited by hypoxic challenge in isoflurane-anesthetized rats.

Authors:  James P Mendoza; Rachael J Passafaro; Santhosh M Baby; Alex P Young; James N Bates; Benjamin Gaston; Stephen J Lewis
Journal:  J Appl Physiol (1985)       Date:  2014-04-17

Review 5.  An Update on Thiol Signaling: S-Nitrosothiols, Hydrogen Sulfide and a Putative Role for Thionitrous Acid.

Authors:  Nadzeya Marozkina; Benjamin Gaston
Journal:  Antioxidants (Basel)       Date:  2020-03-10

6.  S-nitroso-L-cysteine stereoselectively blunts the adverse effects of morphine on breathing and arterial blood gas chemistry while promoting analgesia.

Authors:  Paulina M Getsy; Alex P Young; James N Bates; Santhosh M Baby; James M Seckler; Alan Grossfield; Yee-Hsee Hsieh; Tristan H J Lewis; Michael W Jenkins; Benjamin Gaston; Stephen J Lewis
Journal:  Biomed Pharmacother       Date:  2022-07-26       Impact factor: 7.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.